Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kam

Showing results (161-170 of 243) with videos related to

Pageof 25
Sort By:
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|May 23, 2019
Development and Evaluation of a Cognitive Aid Booklet for Use in Rapid Response ScenariosOscar J L Mitchell, Andrew Lehr, Michelle Lo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 6, 2010
Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevanceK M Kam, A Sloutsky, C W Yip, et al.
Oral Oncology|October 16, 2013
Current controversies in radiotherapy for nasopharyngeal carcinoma (NPC)Michael K M Kam, Frank C S Wong, Dora L W Kwong, et al.
Archives of Biochemistry and Biophysics|February 1, 1995
Mammalian tissue trypsin-like enzymes: substrate specificity and inhibitory potency of substituted isocoumarin mechanism-based inhibitors, benzamidine derivatives, and arginine fluoroalkyl ketone transition-state inhibitorsC M Kam, M A Hernandez, G S Patil, et al.
Journal of Medicinal Chemistry|April 29, 1994
Mechanism-based isocoumarin inhibitors for blood coagulation serine proteases. Effect of the 7-substituent in 7-amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on inhibitory and anticoagulant potencyC M Kam, J E Kerrigan, R R Plaskon, et al.
Journal of Clinical Microbiology|September 18, 2009
Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test resultsA Van Deun, L Barrera, I Bastian, et al.
American Journal of Respiratory and Critical Care Medicine|June 25, 1998
Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis. Initial reportC M Tam, S L Chan, C W Lam, et al.
Journal of Applied Microbiology|September 22, 2010
Usefulness of resistant gene markers for predicting treatment outcome on second-line anti-tuberculosis drugsK L Leung, C W Yip, Y L Yeung, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 21, 2008
Risk factors for multidrug-resistant tuberculosis in Hong KongW S Law, W W Yew, C Chiu Leung, et al.
International Journal of Antimicrobial Agents|August 1, 1996
Emerging resistance in Salmonella enterica serotype Typhi in Hong KongJ M Ling, N W Lo, Y M Ho, et al.
Pageof 25

Showing results (161-170 of 243) with videos related to

Sort By:
Pageof 25
Simulation in Healthcare : Journal of the Society for Simulation in Healthcare|May 23, 2019
Development and Evaluation of a Cognitive Aid Booklet for Use in Rapid Response ScenariosOscar J L Mitchell, Andrew Lehr, Michelle Lo, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 6, 2010
Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevanceK M Kam, A Sloutsky, C W Yip, et al.
Oral Oncology|October 16, 2013
Current controversies in radiotherapy for nasopharyngeal carcinoma (NPC)Michael K M Kam, Frank C S Wong, Dora L W Kwong, et al.
Archives of Biochemistry and Biophysics|February 1, 1995
Mammalian tissue trypsin-like enzymes: substrate specificity and inhibitory potency of substituted isocoumarin mechanism-based inhibitors, benzamidine derivatives, and arginine fluoroalkyl ketone transition-state inhibitorsC M Kam, M A Hernandez, G S Patil, et al.
Journal of Medicinal Chemistry|April 29, 1994
Mechanism-based isocoumarin inhibitors for blood coagulation serine proteases. Effect of the 7-substituent in 7-amino-4-chloro-3-(isothioureidoalkoxy)isocoumarins on inhibitory and anticoagulant potencyC M Kam, J E Kerrigan, R R Plaskon, et al.
Journal of Clinical Microbiology|September 18, 2009
Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test resultsA Van Deun, L Barrera, I Bastian, et al.
American Journal of Respiratory and Critical Care Medicine|June 25, 1998
Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis. Initial reportC M Tam, S L Chan, C W Lam, et al.
Journal of Applied Microbiology|September 22, 2010
Usefulness of resistant gene markers for predicting treatment outcome on second-line anti-tuberculosis drugsK L Leung, C W Yip, Y L Yeung, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|August 21, 2008
Risk factors for multidrug-resistant tuberculosis in Hong KongW S Law, W W Yew, C Chiu Leung, et al.
International Journal of Antimicrobial Agents|August 1, 1996
Emerging resistance in Salmonella enterica serotype Typhi in Hong KongJ M Ling, N W Lo, Y M Ho, et al.
Pageof 25